Skip to content
★ Sign in to follow
ChoA Pharmaceutical Co., Ltd. logo

ChoA Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea

조아제약

KR·Mcap ₩15BHealth Care

No insider purchase over the last 90 days. The latest, by 조성배, was filed 06 Oct 2022.

ChoA Pharmaceutical Co., Ltd.: what insiders have been doing

Every trade that managers of ChoA Pharmaceutical Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. From 10 November 2025 to 10 November 2026, the disclosure feed for ChoA Pharmaceutical Co., Ltd. logged 2 filings by 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Our records for ChoA Pharmaceutical Co., Ltd. go back to 2021, with 3 purchases and no sales on the open market in total.

No insider has bought ChoA Pharmaceutical Co., Ltd. shares on the open market in the past twelve months.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
3 ops. · all time
Sell Volume
n/a
n/a
Fundamental score
Ranked 25,267 of 26,911 companies
17.0
score / 100
Value
5
Quality
29
FCF yld-39%
Earn yld-50%
EV/EBITDA·
ROE-12%
Gross mgn37%
Net mgn-11%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,425
Analyst consensus
·
Income statement
Revenue₩59.3B
Gross profit₩21.9B37% margin
EBITDA-₩2.8B-5% margin
Net income-₩6.8B-4.6% margin
Valuation
Beta0.54
Balance sheet & cash
Market cap₩15B
Total debt₩27.3B
Free Cash Flow-₩5.3B
Debt / Equity84%
Profitability & ownership
ROE-11.8%
ROA-3.7%
% insiders20.0%
% institutions0.0%
Last declaration on 19 June 2026
Declarations11 total
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    0DART
    44,000 sharesShareKRXDART:20221006000094
    Canonical exit: 29 Dec 2022 (T+90)
  • ▲
    Executives
    0DART
    44,000 sharesShareKRXDART:20221006000097
    Canonical exit: 2 Jan 2023 (T+90)
  • ▲
    Executives
    0DART
    44,000 sharesShareKRXDART:20221006000093
    Canonical exit: 3 Jan 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

11 of 11 declarations

About ChoA Pharmaceutical Co., Ltd.

조아제약 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing and distribution of pharmaceutical products.